AstraZeneca’s $50B U.S. Investment: Pharma’s Future

AstraZeneca's $50B U.S. investment signals a new era for pharma. Will tariffs reshape the industry? Discover the bold strategy behind...

22/07/2025

2 views

Trump’s Tariffs: Economic Risk or Market Hype?

Trump's hefty tariffs on copper and pharmaceuticals are shaking markets. Will they ignite inflation or just fade away? Click to...

09/07/2025

3 views

GSK’s Q1 2025 results dazzle with strong earnings and tariff-proof strategies. How is the pharma giant staying ahead? Click to...

30/04/2025

1 views

Roche's $50B U.S. bet creates thousands of jobs and new facilities. Will it shield pharma from tariffs? Click to uncover...

22/04/2025

0 views